CVE-2022-22792: MobiSoft - MobiPlus User Take Over and Improper Handling of url Parameters Attacker can navigate to specific u
CVE-2022-22792 is a medium-severity flaw (CVSS 6.6) affecting mobisoft - mobiplus. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
MobiSoft - MobiPlus User Take Over and Improper Handling of url Parameters Attacker can navigate to specific url which will expose all the users and password in clear text. http://IP/MobiPlusWeb/Handlers/MainHandler.ashx?MethodName=GridData&GridName=Users
Why this priority
- No elevated risk signals yet
No fix is published yet: follow the downgrade or mitigation steps.
Risk facts
| CVSS score | 6.6 (Medium) |
| Attack vector | Local |
| Attack complexity | Low |
| Privileges needed | None |
| User interaction | Required |
| EPSS exploit chance | 0.6% (top 52%) |
| CISA exploited list | No |
| Weakness | CWE-233 |
| Published | 2022-02-16 |
| Last modified | 2026-06-17 |
Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2022-22792?
mobisoft - mobiplus: mitigate or apply the listed mitigation. Exact commands for each OS are on this page.
Is CVE-2022-22792 being exploited?
CVE-2022-22792 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2022-22792 affect?
CVE-2022-22792 affects mobisoft - mobiplus. Severity is medium (CVSS 6.6). MobiSoft - MobiPlus User Take Over and Improper Handling of url Parameters Attacker can navigate to specific url which will expose all the users and password in clear text. http://IP/MobiPlusWeb/Handlers/MainHandler.ashx?MethodName=GridData
How urgent is CVE-2022-22792?
Priority 35/100. No elevated risk signals yet.